Common BP Drug May Prevent Resistance to Tarceva in NSCLC Patients
News
A blood pressure-lowering drug called Edecrin (ethacrynic acid) may be used to prevent resistance to the lung cancer agent Tarceva (erlotinib), scientists from Imperial College London and Fudan University in ... Read more